Advisors to BGF on their £6 million investment into Signify Research

Wilson Partners supported BGF on their £6 million investment into Signify Research, a healthcare technology company.

Deal overview

BGF has completed a £6 million investment into Signify Research, a specialist healthtech market intelligence provider. The multi-million-pound investment aims to accelerate Signify Research’s growth, and expand its market presence as a trusted supplier of high-quality research, consultancy and market intelligence to the global healthcare technology industry.

Signify Research’s in-house research team provide unrivalled subject matter expertise and data-driven insights across its key coverage areas, which business leaders use to guide strategic decision making. These include Medical Imaging, Clinical Care, Digital Health, Diagnostic and Lifesciences, Healthcare IT and AI in Healthcare.

Following BGF’s investment, Signify Research will continue to focus on providing reliable and insightful services to its customers, while increasing the breadth of its coverage areas and the depth of research provided.

The business will continue to be led by an experienced management team, including co-founders Steve Holloway (CEO) and Alex Green (COO). Alongside the investment, Signify Research’s leadership team has also been bolstered with the appointment of Gareth Miller as Non-Executive Chair, following an introduction from BGF’s Talent Network team.

Dan James, Director – Head of Corporate Finance, at Wilson Partners commented: “We were delighted to support Signify and GT with a focussed piece of vendor financial due diligence in support of attracting offers for the business. We were then able to join up with
BGF, to provide additional due diligence to get the deal closed. A pleasure working with all parties on a great deal.”